세포 동결 배지 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 유형별, 세포배양 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Cell Freezing Media Market Size, Share & Trends Analysis Report By Product, By Type, By Cell Culture Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

US $ 5,950 ￦ 8,626,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,076,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,976,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

세포 동결 배지 시장 개요

세계의 세포 동결 배지 시장 규모는 2025년에 12억 3,000만 달러로 추정되며, 2033년에 23억 7,000만 달러에 달할 것으로 예측됩니다.

2026년부터 2033년까지 9.0%의 연평균 성장률을 보일 것으로 예상됩니다. 시장 성장은 세포 동결 배지를 자체 동결 준비의 대체 수단으로 채택이 증가하고, 기존 동결 기술에 비해 즉시 사용 가능한 동결보존 배지의 장점에 기인하는 것으로 판단됩니다.

또한, 다양한 최종사용자들의 효과적인 동결 배지에 대한 수요 증가와 주요 시장 진입 업체들의 다양한 신제품 출시가 시장 성장을 촉진할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련 시장 전망
• 시장 동향과 전망
• 시장 역학
• 비즈니스 환경 분석
  • PESTLE 분석
  • Porter's Five Forces 분석

제4장 제품별 비즈니스 분석

• 세계의 세포 동결 배지 시장 제품별 변동 분석
• 세계의 세포 동결 배지 시장 규모와 동향 분석(제품별), 2021-2033년
• DMSO
• 글리세롤
• 기타

제5장 유형별 비즈니스 분석

• 세계의 세포 동결 배지 시장 유형별 변동 분석
• 세계의 세포 동결 배지 시장 규모와 동향 분석(유형별), 2021-2033년
• 슬로우 프리즈
• 유리화

제6장 세포배양 유형별 비즈니스 분석

• 세계의 세포 동결 배지 시장 세포배양 유형별 변동 분석
• 세계의 세포 동결 배지 시장 규모와 동향 분석(세포배양 유형별), 2021-2033년
• 현탁 세포배양
• 2D 세포배양
• 3D 세포배양
• 기타

제7장 용도별 비즈니스 분석

• 세계의 세포 동결 배지 시장 : 용도별 변동 분석
• 세계의 세포 동결 배지 시장 규모와 동향 분석(용도별), 2021-2033년
• 줄기세포
• 암세포주
• 생식세포
• 일차세포
• 바이오 생산 세포주
• 기타

제8장 최종 용도별 비즈니스 분석

• 세계의 세포 동결 배지 시장 : 최종 용도별 변동 분석
• 세계의 세포 동결 배지 시장 규모와 동향 분석(최종 용도별), 2021-2033년
• 제약 바이오테크놀러지 기업
• 학술·연구기관
• 바이오뱅크
• 체외수정(IVF) 클리닉
• 기타

제9장 세포 동결 배지 시장 : 지역별, 추정·동향 분석(제품별, 유형별, 세포배양 유형별, 용도별, 최종 용도별)

• 지역별 대시보드
• 시장 규모 및 예측과 동향 분석, 2021-2033년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제10장 경쟁 구도

• 기업 분류
• 전략 매핑
• 2025년의 기업 시장 상황 분석
• 기업 개요/리스트
  • Merck KGaA
  • Sartorius AG
  • HiMedia Laboratories
  • Thermo Fisher Scientific Inc.
  • Bio-Life Solutions, Inc.
  • Bio-Techne
  • PromoCell GmbH
  • Capricorn Scientific
  • Vitrolife AB
  • AMSBIO
  • ZENOGEN PHARMA CO., LTD.

KSM

영문 목차

영문목차

Cell Freezing Media Market Summary

The global cell freezing media market size was estimated at USD 1.23 billion in 2025 and is projected to reach USD 2.37 billion by 2033, growing at a CAGR of 9.0% from 2026 to 2033. The market's growth can be attributed to increasing adoption of cell freezing media as an alternative to in-house freezing preparations and the benefits of ready-to-use cryo-preservative media over conventional freezing techniques.

Moreover, rising demand for effective freezing media across a wide range of end-users and various new products launched by key market players are anticipated to fuel market growth.

Global Cell Freezing Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell freezing media market based on product, type, cell culture type, application, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• DMSO
  • With Serum
  • Without Serum
• Glycerol
  • With Serum
  • Without Serum
• Others
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Slow Freezing
• Vitrification
• Cell Culture Type Outlook (Revenue, USD Million, 2021 - 2033)
• Suspension Cell Culture
• 2D Cell Culture
• 3D Cell Culture
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Stem Cells
  • Mesenchymal Stem Cells (MSCs)
  • Hematopoietic Stem Cells (HSCs)
  • Induced Pluripotent Stem Cells (iPSCs)
  • Embryonic Stem Cells (ESCs)
  • Others
• Cancer Cell Lines
• Reproductive Cells
• Primary Cells
• Bioproduction Cell Lines
  • CHO Cells
  • HEK293 Cells
  • BHK
  • Others
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceuticals and Biotechnology Companies
• Academic and Research Institutes
• Biobanks
  • Stem Cells
  • Reproductive Cells
  • Other Cells
• IVF Clinics
• Other End Use
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Cell Culture Type
  • 1.2.4. Application
  • 1.2.5. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Advancements in cryopreservation technology
    • 3.3.1.2. Rising demand from expanding cell-based research and stem cell therapies
    • 3.3.1.3. Increasing biobanking activities
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. Cost associated with cryopreservation and cell freezing media
    • 3.3.2.2. Stringent regulatory requirements
• 3.4. Business Environment Analysis
  • 3.4.1. PESTLE Analysis
  • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Cell Freezing Media Market Product, Movement Analysis
• 4.3. Global Cell Freezing Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. DMSO
  • 4.4.1. Global DMSO market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.1.1. With Serum
      • 4.4.1.1.1. Global with serum media market estimates and forecasts, 2021 - 2033 (USD million)
    • 4.4.1.2. Without Serum
      • 4.4.1.2.1. Global without serum media market estimates and forecasts, 2021 - 2033 (USD million)
• 4.5. Glycerol
  • 4.5.1. Global glycerol media market estimates and forecasts, 2021 - 2033 (USD million)
    • 4.5.1.1. With Serum
      • 4.5.1.1.1. Global with serum media market estimates and forecasts, 2021 - 2033 (USD million)
    • 4.5.1.2. Without Serum
      • 4.5.1.2.1. Global without serum media market estimates and forecasts, 2021 - 2033 (USD million)
• 4.6. Others
  • 4.6.1. Global others media market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 5. Type Business Analysis

• 5.1. Type Segment Dashboard
• 5.2. Global Cell Freezing Media Market Type, Movement Analysis
• 5.3. Global Cell Freezing Media Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Slow Freezing
  • 5.4.1. Global slow freezing market estimates and forecasts, 2021 - 2033 (USD million)
• 5.5. Vitrification
  • 5.5.1. Global vitrification market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 6. Cell Culture Type Business Analysis

• 6.1. Cell Culture Type Segment Dashboard
• 6.2. Global Cell Freezing Media Market Cell Culture Type, Movement Analysis
• 6.3. Global Cell Freezing Media Market Size & Trend Analysis, by Cell Culture Type, 2021 to 2033 (USD Million)
• 6.4. Suspension Cell Culture
  • 6.4.1. Global suspension cell culture market estimates and forecasts, 2021 - 2033 (USD million)
• 6.5. 2D Cell Culture
  • 6.5.1. Global 2D cell culture market estimates and forecasts, 2021 - 2033 (USD million)
• 6.6. 3D Cell Culture
  • 6.6.1. Global 3D cell culture market estimates and forecasts, 2021 - 2033 (USD million)
• 6.7. Others
  • 6.7.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. Application Business Analysis

• 7.1. Application Segment Dashboard
• 7.2. Global Cell Freezing Media Market Application, Movement Analysis
• 7.3. Global Cell Freezing Media Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 7.4. Stem Cells
  • 7.4.1. Global stem cells market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.4.1.1. Mesenchymal stem cells (MSCs)
      • 7.4.1.1.1. Global mesenchymal stem cells (MSCs) market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.4.1.2. Hematopoietic stem cells (HSCs)
      • 7.4.1.2.1. Global hematopoietic stem cells (HSCs) market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.4.1.3. Induced pluripotent stem cells (iPSCs)
      • 7.4.1.3.1. Global induced pluripotent stem cells (iPSCs) market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.4.1.4. Embryonic Stem Cells (ESCs)
      • 7.4.1.4.1. Global embryonic stem cells (ESCs) market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.4.1.5. Others
      • 7.4.1.5.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)
• 7.5. Cancer cell lines
  • 7.5.1. Global cancer cell lines market estimates and forecasts, 2021 - 2033 (USD million)
• 7.6. Reproductive Cells
  • 7.6.1. Global reproductive cells market estimates and forecasts, 2021 - 2033 (USD million)
• 7.7. Primary Cells
  • 7.7.1. Global primary cells market estimates and forecasts, 2021 - 2033 (USD million)
• 7.8. Bioproduction Cell Lines
  • 7.8.1. Global bioproduction cell lines market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.8.1.1. CHO cells
      • 7.8.1.1.1. Global CHO cells market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.8.1.2. Hek293 cells
      • 7.8.1.2.1. Global Hek293 cells market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.8.1.3. Bhk
      • 7.8.1.3.1. Global Bhk market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.8.1.4. Others
      • 7.8.1.4.1. Global others market estimates and forecasts, 2021 - 2033 (USD million)
• 7.9. Others
  • 7.9.1. Global other application market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 8. End Use Business Analysis

• 8.1. End Use Segment Dashboard
• 8.2. Global Cell Freezing Media Market End Use, Movement Analysis
• 8.3. Global Cell Freezing Media Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Pharmaceutical & Biotechnology Companies
  • 8.4.1. Global pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD million)
• 8.5. Academic and Research Institutes
  • 8.5.1. Global academic and research institutes market estimates and forecasts, 2021 - 2033 (USD million)
• 8.6. Biobanks
  • 8.6.1. Global biobanks market estimates and forecasts, 2021 - 2033 (USD million)
    • 8.6.1.1. Stem Cells
      • 8.6.1.1.1. Global stem cells market estimates and forecasts, 2021 - 2033 (USD million)
    • 8.6.1.2. Reproductive Cells
      • 8.6.1.2.1. Global reproductive cells market estimates and forecasts, 2021 - 2033 (USD million)
    • 8.6.1.3. Other cells
      • 8.6.1.3.1. Global other cells market estimates and forecasts, 2021 - 2033 (USD million)
• 8.7. IVF Clinics
  • 8.7.1. Global IVF clinics market estimates and forecasts, 2021 - 2033 (USD million)
• 8.8. Other End Use
  • 8.8.1. Global other end user market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 9. Cell Freezing Media Market: Regional Estimates and Trend Analysis, by Product, Type, Cell Culture Type, Application, & End-Use

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America cell freezing media market, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Target Disease Prevalence
    • 9.3.2.3. Competitive Scenario
    • 9.3.2.4. Regulatory Framework
    • 9.3.2.5. U.S. cell freezing media market, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Target Disease Prevalence
    • 9.3.3.3. Competitive Scenario
    • 9.3.3.4. Regulatory Framework
    • 9.3.3.5. Canada cell freezing media market, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Target Disease Prevalence
    • 9.3.4.3. Competitive Scenario
    • 9.3.4.4. Regulatory Framework
    • 9.3.4.5. Mexcio cell freezing media market, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe cell freezing media market, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Target Disease Prevalence
    • 9.4.2.3. Competitive Scenario
    • 9.4.2.4. Regulatory Framework
    • 9.4.2.5. UK cell freezing media market, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Target Disease Prevalence
    • 9.4.3.3. Competitive Scenario
    • 9.4.3.4. Regulatory Framework
    • 9.4.3.5. Germany cell freezing media market, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Target Disease Prevalence
    • 9.4.4.3. Competitive Scenario
    • 9.4.4.4. Regulatory Framework
    • 9.4.4.5. France cell freezing media market, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Target Disease Prevalence
    • 9.4.5.3. Competitive Scenario
    • 9.4.5.4. Regulatory Framework
    • 9.4.5.5. Italy cell freezing media market, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Target Disease Prevalence
    • 9.4.6.3. Competitive Scenario
    • 9.4.6.4. Regulatory Framework
    • 9.4.6.5. Spain cell freezing media market, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Target Disease Prevalence
    • 9.4.7.3. Competitive Scenario
    • 9.4.7.4. Regulatory Framework
    • 9.4.7.5. Denmark cell freezing media market, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Target Disease Prevalence
    • 9.4.8.3. Competitive Scenario
    • 9.4.8.4. Regulatory Framework
    • 9.4.8.5. Sweden cell freezing media market, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Target Disease Prevalence
    • 9.4.9.3. Competitive Scenario
    • 9.4.9.4. Regulatory Framework
    • 9.4.9.5. Norway cell freezing media market, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific cell freezing media market, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Target Disease Prevalence
    • 9.5.2.3. Competitive Scenario
    • 9.5.2.4. Regulatory Framework
    • 9.5.2.5. Japan cell freezing media market, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Target Disease Prevalence
    • 9.5.3.3. Competitive Scenario
    • 9.5.3.4. Regulatory Framework
    • 9.5.3.5. China cell freezing media market, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Target Disease Prevalence
    • 9.5.4.3. Competitive Scenario
    • 9.5.4.4. Regulatory Framework
    • 9.5.4.5. India cell freezing media market, 2021 - 2033 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Target Disease Prevalence
    • 9.5.5.3. Competitive Scenario
    • 9.5.5.4. Regulatory Framework
    • 9.5.5.5. Australia cell freezing media market, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Target Disease Prevalence
    • 9.5.6.3. Competitive Scenario
    • 9.5.6.4. Regulatory Framework
    • 9.5.6.5. Thailand cell freezing media market, 2021 - 2033 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Target Disease Prevalence
    • 9.5.7.3. Competitive Scenario
    • 9.5.7.4. Regulatory Framework
    • 9.5.7.5. South Korea cell freezing media market, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America cell freezing media market, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Target Disease Prevalence
    • 9.6.2.3. Competitive Scenario
    • 9.6.2.4. Regulatory Framework
    • 9.6.2.5. Brazil cell freezing media market, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Target Disease Prevalence
    • 9.6.3.3. Competitive Scenario
    • 9.6.3.4. Regulatory Framework
    • 9.6.3.5. Argentina cell freezing media market, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA cell freezing media market, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Target Disease Prevalence
    • 9.7.2.3. Competitive Scenario
    • 9.7.2.4. Regulatory Framework
    • 9.7.2.5. South Africa cell freezing media market, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Target Disease Prevalence
    • 9.7.3.3. Competitive Scenario
    • 9.7.3.4. Regulatory Framework
    • 9.7.3.5. Saudi Arabia cell freezing media market, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Target Disease Prevalence
    • 9.7.4.3. Competitive Scenario
    • 9.7.4.4. Regulatory Framework
    • 9.7.4.5. UAE cell freezing media market, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Target Disease Prevalence
    • 9.7.5.3. Competitive Scenario
    • 9.7.5.4. Regulatory Framework
    • 9.7.5.5. Kuwait cell freezing media market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2025
• 10.4. Company Profiles/Listing
  • 10.4.1. Merck KGaA
    • 10.4.1.1. Overview
    • 10.4.1.2. Financial Performance
    • 10.4.1.3. Product Benchmarking
    • 10.4.1.4. Strategic Initiatives
  • 10.4.2. Sartorius AG
    • 10.4.2.1. Overview
    • 10.4.2.2. Financial Performance
    • 10.4.2.3. Product Benchmarking
    • 10.4.2.4. Strategic Initiatives
  • 10.4.3. HiMedia Laboratories
    • 10.4.3.1. Overview
    • 10.4.3.2. Financial Performance
    • 10.4.3.3. Product Benchmarking
    • 10.4.3.4. Strategic Initiatives
  • 10.4.4. Thermo Fisher Scientific Inc.
    • 10.4.4.1. Overview
    • 10.4.4.2. Financial Performance
    • 10.4.4.3. Product Benchmarking
    • 10.4.4.4. Strategic Initiatives
  • 10.4.5. Bio-Life Solutions, Inc.
    • 10.4.5.1. Overview
    • 10.4.5.2. Financial Performance
    • 10.4.5.3. Product Benchmarking
    • 10.4.5.4. Strategic Initiatives
  • 10.4.6. Bio-Techne
    • 10.4.6.1. Overview
    • 10.4.6.2. Financial Performance
    • 10.4.6.3. Product Benchmarking
    • 10.4.6.4. Strategic Initiatives
  • 10.4.7. PromoCell GmbH
    • 10.4.7.1. Overview
    • 10.4.7.2. Financial Performance
    • 10.4.7.3. Product Benchmarking
    • 10.4.7.4. Strategic Initiatives
  • 10.4.8. Capricorn Scientific
    • 10.4.8.1. Overview
    • 10.4.8.2. Financial Performance
    • 10.4.8.3. Product Benchmarking
    • 10.4.8.4. Strategic Initiatives
  • 10.4.9. Vitrolife AB
    • 10.4.9.1. Overview
    • 10.4.9.2. Financial Performance
    • 10.4.9.3. Product Benchmarking
    • 10.4.9.4. Strategic Initiatives
  • 10.4.10. AMSBIO
    • 10.4.10.1. Overview
    • 10.4.10.2. Financial Performance
    • 10.4.10.3. Product Benchmarking
    • 10.4.10.4. Strategic Initiatives
  • 10.4.11. ZENOGEN PHARMA CO., LTD.
    • 10.4.11.1. Overview
    • 10.4.11.2. Financial Performance
    • 10.4.11.3. Product Benchmarking
    • 10.4.11.4. Strategic Initiatives

관련자료